One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial Article

Industry Collaboration International Collaboration

cited authors

  • Pratley, R.; Nauck, M.; Bailey, T.; Montanya, E.; Cuddihy, R.; Filetti, S.; Garber, A.; Thomsen, A. B.; Hartvig, H.; Davies, M.; 1860-LIRA-DPP-4 Study Grp

Publication Date

  • April 1, 2011

webpage

category

start page

  • 397

end page

  • 407

volume

  • 65

issue

  • 4